{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:41:37Z","timestamp":1768707697192,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3043514"],"award-info":[{"award-number":["2023YFC3043514"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2303100"],"award-info":[{"award-number":["2022YFC2303100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["ZYCXTD2023002"],"award-info":[{"award-number":["ZYCXTD2023002"]}]},{"name":"Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["QNCXTD2023002"],"award-info":[{"award-number":["QNCXTD2023002"]}]},{"name":"2024 Special Project of the National Key Laboratory of Innovative Drugs for Antiviral Infectious Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85677-w","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:42:46Z","timestamp":1743450166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of azvudine versus nirmatrelvir\/ritonavir in cancer patients with COVID-19"],"prefix":"10.1038","volume":"15","author":[{"given":"Bohan","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guotao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zujiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"85677_CR1","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray, F., Laversanne, M., Weiderpass, E. & Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029\u20133030 (2021).","journal-title":"Cancer"},{"key":"85677_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"Cancer J. Clin."},{"key":"85677_CR3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(13)62224-2","volume":"383","author":"P Vineis","year":"2014","unstructured":"Vineis, P. & Wild, C. P. Global cancer patterns: causes and prevention. Lancet 383, 549\u2013557 (2014).","journal-title":"Lancet"},{"key":"85677_CR4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1053\/j.seminoncol.2015.05.003","volume":"42","author":"D Pardoll","year":"2015","unstructured":"Pardoll, D. Cancer and the immune system: basic concepts and targets for intervention. Semin. Oncol. 42, 523\u2013538 (2015).","journal-title":"Semin. Oncol."},{"key":"85677_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2017.07.010","volume":"85","author":"A Sica","year":"2017","unstructured":"Sica, A. & Massarotti, M. Myeloid suppressor cells in cancer and autoimmunity. J. Autoimmun. 85, 117\u2013125 (2017).","journal-title":"J. Autoimmun."},{"key":"85677_CR6","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","volume":"395","author":"LY Lee","year":"2020","unstructured":"Lee, L. Y. et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet (Lond. Engl.) 395, 1919\u20131926 (2020).","journal-title":"Lancet (Lond. Engl.)"},{"key":"85677_CR7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1470-2045(09)70069-5","volume":"10","author":"M Kamboj","year":"2009","unstructured":"Kamboj, M. & Sepkowitz, K. A. Nosocomial infections in patients with cancer. Lancet Oncol. 10, 589\u2013597 (2009).","journal-title":"Lancet Oncol."},{"key":"85677_CR8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","volume":"19","author":"H Yang","year":"2021","unstructured":"Yang, H. & Rao, Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat. Rev. Microbiol. 19, 685\u2013700 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"85677_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2021","unstructured":"V\u2019kovski, P., Kratzel, A., Steiner, S., Stalder, H. & Thiel, V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 19, 155\u2013170 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"85677_CR10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"85677_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang, W. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 21, 335\u2013337 (2020).","journal-title":"Lancet Oncol."},{"key":"85677_CR12","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","volume":"31","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann. Oncol. 31, 894\u2013901 (2020).","journal-title":"Ann. Oncol."},{"key":"85677_CR13","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N Engl. J. Med. 386, 1397\u20131408 (2022).","journal-title":"N Engl. J. Med."},{"key":"85677_CR14","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1093\/cid\/ciac443","volume":"76","author":"R Najjar-Debbiny","year":"2023","unstructured":"Najjar-Debbiny, R. et al. Effectiveness of paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients. Clin. Infect. Dis. 76, e342\u2013e349 (2023).","journal-title":"Clin. Infect. Dis."},{"key":"85677_CR15","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1021\/acs.jmedchem.0c00940","volume":"63","author":"L Sun","year":"2020","unstructured":"Sun, L. et al. Mechanistic insight into antiretroviral potency of 2\u2019-deoxy-2\u2019-\u03b2-fluoro-4\u2019-azidocytidine (FNC) with a long-lasting effect on HIV-1 prevention. J. Med. Chem. 63, 8554\u20138566 (2020).","journal-title":"J. Med. Chem."},{"key":"85677_CR16","unstructured":"National Medical Products Administratior. The National Medical Products Administration has conditionally approved the marketing of Azvudine Tablets (2024, accessed 26 Dec 2024). https:\/\/www.nmpa.gov.cn\/zhuanti\/cxylqx\/cxypxx\/20210721142223181.html."},{"key":"85677_CR17","first-page":"e2001435","volume":"7","author":"Z Ren","year":"2020","unstructured":"Ren, Z. et al. A randomized, open-label, controlled clinical trial of azvudine tablets in the treatment of mild and common COVID-19, a pilot study. Adv. Sci. (Weinh.) 7, e2001435 (2020).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"85677_CR18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41392-021-00835-6","volume":"6","author":"JL Zhang","year":"2021","unstructured":"Zhang, J. L. et al. Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients. Signal. Transduct. Target. Therapy  6, 414 (2021).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"85677_CR19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","volume":"10","author":"M Dai","year":"2020","unstructured":"Dai, M. et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 10, 783\u2013791 (2020).","journal-title":"Cancer Discov."},{"key":"85677_CR20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.006","volume":"81","author":"J Ma","year":"2020","unstructured":"Ma, J., Yin, J., Qian, Y. & Wu, Y. Clinical characteristics and prognosis in cancer patients with COVID-19: a single center\u2019s retrospective study. J. Infect. 81, 318\u2013356 (2020).","journal-title":"J. Infect."},{"key":"85677_CR21","doi-asserted-by":"crossref","first-page":"e2551","DOI":"10.1002\/rmv.2551","volume":"34","author":"B Amani","year":"2024","unstructured":"Amani, B. & Amani, B. Azvudine versus paxlovid in COVID-19: a systematic review and meta-analysis. Rev. Med. Virol. 34, e2551 (2024).","journal-title":"Rev. Med. Virol."},{"key":"85677_CR22","doi-asserted-by":"crossref","first-page":"e0298772","DOI":"10.1371\/journal.pone.0298772","volume":"19","author":"B Amani","year":"2024","unstructured":"Amani, B. & Amani, B. Effectiveness and safety of azvudine in COVID-19: a systematic review and meta-analysis. PLoS One 19, e0298772 (2024).","journal-title":"PLoS One"},{"key":"85677_CR23","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.7150\/jca.91530","volume":"15","author":"F Li","year":"2024","unstructured":"Li, F. et al. A retrospective analysis of azvudine in patients with COVID-19 and pre-existing cancer. J. Cancer 15, 2442\u20132447 (2024).","journal-title":"J. Cancer"},{"key":"85677_CR24","doi-asserted-by":"publisher","unstructured":"Guermazi, D., Arvanitis, P., Vieira, K., Warner, J. L. & Farmakiotis, D. Oral antivirals for COVID-19 among patients with cancer. Res. Square.  https:\/\/doi.org\/10.21203\/rs.3.rs-3876022\/v1 (2024).","DOI":"10.21203\/rs.3.rs-3876022\/v1"},{"key":"85677_CR25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41467-019-09212-y","volume":"10","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. NKG2A is a NK cell exhaustion checkpoint for HCV persistence. Nat. Commun. 10, 1507 (2019).","journal-title":"Nat. Commun."},{"key":"85677_CR26","first-page":"100452","volume":"4","author":"K Anwar","year":"2023","unstructured":"Anwar, K., Nguyen, L., Nagasaka, M., Ou, S. H. I. & Chan, A. Overview of drug-drug interactions between ritonavir-boosted nirmatrelvir (paxlovid) and targeted therapy and supportive care for lung cancer. JTO Clin. Res. Rep. 4, 100452 (2023).","journal-title":"JTO Clin. Res. Rep."},{"key":"85677_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0090-4295(99)00451-3","volume":"54","author":"U Vaishampayan","year":"1999","unstructured":"Vaishampayan, U., Parchment, R. E., Jasti, B. R. & Hussain, M. Taxanes: an overview of the pharmacokinetics and pharmacodynamics. Urology 54, 22\u201329 (1999).","journal-title":"Urology"},{"key":"85677_CR28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0022-3565(24)39081-0","volume":"294","author":"D Yao","year":"2000","unstructured":"Yao, D., Ding, S., Burchell, B., Wolf, C. R. & Friedberg, T. Detoxication of vinca alkaloids by human P450 CYP3A4-mediated metabolism: implications for the development of drug resistance. J. Pharmacol. Exp. Ther. 294, 387\u2013395 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"85677_CR29","doi-asserted-by":"crossref","first-page":"100061","DOI":"10.1016\/j.infpip.2020.100061","volume":"2","author":"M Tobaiqy","year":"2020","unstructured":"Tobaiqy, M. et al. Therapeutic management of patients with COVID-19: a systematic review. Infect. Prev. Pract. 2, 100061 (2020).","journal-title":"Infect. Prev. Pract."},{"key":"85677_CR30","doi-asserted-by":"crossref","first-page":"e21597","DOI":"10.1097\/MD.0000000000021597","volume":"99","author":"K Wang","year":"2020","unstructured":"Wang, K. et al. Therapeutic response to corticosteroids in a critically ill patient with COVID-19: a case report. Med. (Baltim). 99, e21597 (2020).","journal-title":"Med. (Baltim)."},{"key":"85677_CR31","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group","year":"2020","unstructured":"WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. Jama 324, 1330\u20131341 (2020).","journal-title":"Jama"},{"key":"85677_CR32","doi-asserted-by":"crossref","first-page":"13681","DOI":"10.1128\/JVI.01702-07","volume":"81","author":"K Jung","year":"2007","unstructured":"Jung, K. et al. Altered pathogenesis of porcine respiratory coronavirus in pigs due to immunosuppressive effects of dexamethasone: implications for corticosteroid use in treatment of severe acute respiratory syndrome coronavirus. J. Virol. 81, 13681\u201313693 (2007).","journal-title":"J. Virol."},{"key":"85677_CR33","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","volume":"31","author":"N Lee","year":"2004","unstructured":"Lee, N. et al. Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients. J. Clin. Virol. 31, 304\u2013309 (2004).","journal-title":"J. Clin. Virol."},{"key":"85677_CR34","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fphar.2020.01198","volume":"11","author":"Y Ma","year":"2020","unstructured":"Ma, Y. et al. Corticosteroid use in the treatment of COVID-19: a Multicenter Retrospective Study in Hunan, China. Front. Pharmacol. 11, 1198 (2020).","journal-title":"Front. Pharmacol."},{"key":"85677_CR35","doi-asserted-by":"crossref","first-page":"101981","DOI":"10.1016\/j.eclinm.2023.101981","volume":"59","author":"Y Sun","year":"2023","unstructured":"Sun, Y. et al. Oral azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study. EClinicalMedicine 59, 101981 (2023).","journal-title":"EClinicalMedicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85677-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85677-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85677-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:43:48Z","timestamp":1743450228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85677-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85677"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85677-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11022"}}